- Home
- COEP vs DRIO Comparison
COEP vs DRIO Comparison
Compare COEP & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- DRIO
- Stock Information
- Founded
- COEP 2017
- DRIO 2011
- Country
- COEP United States
- DRIO United States
- Employees
- COEP N/A
- DRIO N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- DRIO Medical/Dental Instruments
- Sector
- COEP Health Care
- DRIO Health Care
- Exchange
- COEP Nasdaq
- DRIO Nasdaq
- Market Cap
- COEP 27.4M
- DRIO 30.5M
- IPO Year
- COEP N/A
- DRIO N/A
- Fundamental
- Price
- COEP $9.47
- DRIO $0.71
- Analyst Decision
- COEP
- DRIO Strong Buy
- Analyst Count
- COEP 0
- DRIO 2
- Target Price
- COEP N/A
- DRIO $2.50
- AVG Volume (30 Days)
- COEP 38.0K
- DRIO 118.3K
- Earning Date
- COEP 08-15-2025
- DRIO 08-07-2025
- Dividend Yield
- COEP N/A
- DRIO N/A
- EPS Growth
- COEP N/A
- DRIO N/A
- EPS
- COEP N/A
- DRIO N/A
- Revenue
- COEP $62,874.00
- DRIO $28,034,000.00
- Revenue This Year
- COEP N/A
- DRIO $13.66
- Revenue Next Year
- COEP N/A
- DRIO $24.50
- P/E Ratio
- COEP N/A
- DRIO N/A
- Revenue Growth
- COEP N/A
- DRIO 47.20
- 52 Week Low
- COEP $2.31
- DRIO $0.50
- 52 Week High
- COEP $13.70
- DRIO $1.55
- Technical
- Relative Strength Index (RSI)
- COEP 62.24
- DRIO 52.31
- Support Level
- COEP $7.25
- DRIO $0.69
- Resistance Level
- COEP $9.90
- DRIO $0.74
- Average True Range (ATR)
- COEP 0.63
- DRIO 0.04
- MACD
- COEP 0.26
- DRIO 0.00
- Stochastic Oscillator
- COEP 85.62
- DRIO 57.32
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.